Neuberg Diagnostics Pvt Ltd has completed the merger of Neuberg Supratech Reference Laboratory, Ahmedabad, and Neuberg Anand Reference Laboratory, Bengaluru, setting the ball rolling for its IPO plans, the company said on Wednesday. With the merger, Neuberg Diagnostics brings together two entities to streamline operations and enhance efficiency. The merger also paves the way for Neuberg Diagnostics’ launch of its Initial Public Offering (IPO) by 2024 or 2025. Neuberg Diagnostics Chairman and Managing Director GSK Velu stated that the merger marks a significant step forward in their journey to provide unparalleled healthcare solutions. The acquisition is expected to result in a group gross revenue of over Rs 1,000 crore for Neuberg Diagnostics during the current financial year. The company can leverage its enhanced capabilities to expand and offer a wide range of cutting-edge diagnostic services to patients across India and beyond. The merger has led to a reshuffling of Neuberg Diagnostics’ senior management, with Sandip Shah being elevated as Joint Managing Director and Sujay Prasad as the Chief Medical Director. A Ganesan will continue as the Vice Chairman of Neuberg Diagnostics. The merger aligns with the company’s growth strategy and will attract additional resources for expanding its operations.